Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. In this conversation. Over the last 8 years, insiders at Wave Life Sciences have traded over $18,606,802 worth of Wave Life Sciences stock and bought 14,319,108 units worth $106,704,225 In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. . So they invited their close friends Keri and Ben up for what they expected to be a reality check. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.92B . The gurus listed in this website are not affiliated with GuruFocus.com, LLC. To their delight, Keri and Ben, long-time city dwellers, were immediately taken with the town and the inn, and they, too, embraced the vision of a life filled with New England hospitality, nature, and, adds Ben, equal parts fly fishing and snow shoveling. Kolchinsky Peter Net Worth 2022 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. The current estimated net worth of Dyne Therapeutics, Inc's Peter Kolchinsky is estimated to be about $2.88B . Insider trading is most common in February, with the busiest year in 2023. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . . Currently, Peter is married. var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. All Rights Reserved. But many people worry that Covid-19 will mutate and . Bens wife, Keri, grew up on a red dirt road in small-town Georgia. "And another thread that speaks to need for insurance reform. $20M on February 16, 2023. Hbm Healthcare Investments Cayman Ltd who bought, In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. Current Endpoints readerscan visit their reader profileto add Endpoints Weekly. Save my name, email, and website in this browser for the next time I comment. In this conversation. Come and visit me at the Pacific Water Conference, booth 520! The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. Eric Lefkofsky, Tempus founder and CEO (Photo by Michael Kovac/Getty Images), Christina Aguilera joins Merz Aesthetics' 'Beauty on Your Terms' campaign for Botox rival Xeomin, Hemolytic Anemia Sales Specialist, Rare Genetic Diseases, Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups, Digital therapeutics: The key to maximizing the potential of medicinal assets, What latest wave of layoffs means for biotech; Radiotherapy shortage; Delivering on mRNA's promises; and more, Harder to find homes: Latest wave of biotech layoffs could test the industry, Esperion unveils long-awaited data on cholesterol pill's ability to cut cardiovascular risk, Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight, A radioactive prostate cancer therapy is a last lifeline for patients. Peter Kolchinsky, RA Capital's founder and managing partner, joins to talk about why so many of the policy ideas floated around drug-pricing are wrongheaded. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . Anna is excited about introducing her dressage horse Jurist to the local network of trails. Carl Ashley Morris, Chief Scientific Officer, Add it to the rest of the money and their private deal capacity jumps to $1 billion, with $2.5 billion under management. The most active traders at the company are Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc common stock. The estimated Net Worth of Peter Kolchinsky is at least $105 Milion dollars as of 23 June 2020. We loved the idea of having a second home that was also an inn, but we figured our friends and family would try to talk us out of it, said Anna. Shes currently earning her PhD in European History at Boston. Anna Kolchinsky was born on 03/30/1979 and is 43 years old. During. (LogOut/ The Kolchinskys came. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. . She received a Masters degree in TV production at Boston University and worked in film production in Berlin for several years before returning to Boston, where she met Peter. Boston, MA. and Ian F Smith, Director These . one-time use only and expires after 24 hours. As the Independent Director of Wave Life Sciences, the total compensation of Peter Kolchinsky at Wave Life Sciences is $151,598. Fundamental company data provided by Morningstar, updated daily. Source: https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm. CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. Kolchinsky Peter Ownership Network Ownership Network List of Kolchinsky Peter Name Position Linked company No Data Ownership Network Relation of Kolchinsky Peter Kolchinsky Peter Mailing Address Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Please note this link is one-time use only and is valid for only 24 hours. Jonathan McNeill who sold, In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of, https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. Peter Kolchinsky started RA Capital Management after completing his Ph.D. in virology from Harvard in 2001. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. They will be in plain English and use colorful analogies." Unlock this article along with other benefits by subscribing to one of our paid plans. This investment adviser does not provide advice to individual investors. UCLA CTSI | Accelerating Discoveries Toward Better Health | Main Adam Levy, CFO, . Kolchinsky's new book, The Great American Drug Deal: A New Prescription for Innovative and. Dr. Kolchinsky's RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. The higher rates are proposed to kick in on April 1. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and December 22nd, 2014. . The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. In the interim, they plan to invite, Were not in a rush, Anna explained, and want to take some time to get to know the. In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of $9.83M More than 100 drug developers thinned their organization charts last year. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Carl Ashley Morris who sold, In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. He currently manages a fund that invests in healthcare and biotechnology companies. Required fields are marked *. https://t.co/y9IG2Z5txl" Wallmine is a radically better financial terminal. Recently at Mineralys Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Peter Kolchinsky owns about 1,311,247 units of Mineralys Therapeutics, Inc common stock. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Peter Kolchinsky's largest purchase order was 2,805,045 units , worth over Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Please note the magic link is Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. Your email address will not be published. Change), You are commenting using your Twitter account. The estimated Net Worth of Peter Kolchinsky is at least $96 million dollars as of 23 June 2020. Sign up here. Peter Kolchinsky owns about 1,311,247 units of Mineralys. The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2023-02-17. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. Well be posting shots of the different projects around the inn in the coming weeks, but first we thought you might like to know a little bit about us. Unlock this story instantly and join 161,900+ biopharma pros reading Endpoints daily and it's free. He currently works with the State and Local Government Practice Group of the consulting firm Accenture. Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. He co-founded and runs the Boston-based investment firm RA Capital Management, writes and teaches about biomedical entrepreneurship and its potential to transform global health, serves on the boards of several public and private drug development companies, and has served on the Board of Global Science and Technology for the National . On average, Rajeev trades about 455,121 units every 31 days since 2016. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. Endpoints News Top biotech investor Peter Kolchinsky tees up a new SPAC 3 days after a $300M raise for radiopharmaceuticals play News Dec 9, 2020 Endpoints News RA Capital backs Oxford spinout PepGen with a $45M Series A, seeking to treat Duchenne and other similar diseases Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. and bought an estimated value of $190.71M worth of shares. Peter Kolchinsky. This new fund of theirs arrives well into a go-go era of new startup financing, with a particular focus on building new biotechs. 2004-2023 GuruFocus.com, LLC. Merz has previously enlisted singer-songwriters Joe Jonas and Teyana Taylor, 33 and 31 years old respectively, who tout the anti-wrinkle injection as a solution for frown lines without any unnecessary ingredients., Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. Opinion. In addition, they want to provide guests with ample opportunities to enjoy local arts, food, and activities and look forward to collaborating with local artists, craftsmen, and business owners to come up with interesting packages. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Novartis can't make enough of it, Q&A with Christine Baeder, new chair of the generic industrys AAM, UK government plans to hike revenue clawback rates beginning in April, Merz Aesthetics hands the mic to Christina Aguilera in Botox rival campaign. Come and visit me at the Pacific Water Conference, booth 520! He currently manages a fund that invests in healthcare and biotechnology companies. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. "Stay tuned for more covid and science explainers. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of savvy business sense. Want this in your inbox every Saturday morning? The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.89B . The group has been building an incubator with 19 projects and two startups to their credit. and Catherine James, EVP and General Counsel Baeder explains below not only whats coming for AAM and its member generic drug companies, but also her thoughts on the Inflation Reduction Act and the new five-year FDA user fee deal. The Statutory Scheme, which is governed under UK law, is one of two that companies can use. Peter Kolchinsky: It has infected people in different parts of the world. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss In addition, he makes $151,598 as Independent Director at Wave Life Sciences. The role of insurance and the value of what should be a celebrated national resource - the growing mountain of generic drugs - are overlooked and yet form the foundation of a workable solution.The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. There are 12 executives at Wave Life Sciences getting paid more, with PaulBolno having the highest compensation of $3,581,530. Peters wife, Anna, grew up in Germany, Austria, and France, and came to Boston to attend Wellesley College. The foursome plans to open for guests in the late spring of 2010.